メニュー
Meet the Program Commitee for 2026!
プログラム委員会
-
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division

European Medicines Agency, Netherlands -
Jesper Kjær, MS • Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs

Novo Nordisk, Denmark -
Aimad Torqui • Head of Division European cooperation and veterinary affairs

MEB, Netherlands -
Dimitrios Athanasiou, MBA • Patient Advocate

WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS, Greece -
Seán Byrne • Senior Manager Legal and Regulatory Affairs

European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium -
Angelika Joos, MPharm • Executive Director, Science & Regulatory Policy

MSD, Belgium -
João Duarte, MPharm, MSc • Vice President, Head of Global Regulatory Affairs Excellence

Ipsen, France -
Tim Chesworth • Senior Director Regulatory Affairs

Novartis, United Kingdom -
Angela Currie • Head of New Product Introduction and Regulatory Intelligence, Operations Regulat

AstraZeneca, United Kingdom -
Teresa Eastwood-Kiefer • Global Lead, Regulatory Submission Management

Roche, Switzerland -
Rüdiger Faust, DrSc • Global Regulatory Policy and Intelligence Lead

UCB Biosciences GmbH, Germany -
Chloe Garay, PharmD • Sr. Director, Global Regulatory Intelligence & Policy

Eli Lilly and Company, United Kingdom -
Pedro Franco, PharmD, PhD, MS, MSc • Senior Director for Global Regulatory & Scientific Policy (GRASP)

Merck Serono Limited, United Kingdom -
Stuart Finnie, DrSc, MS • Senior Director, CMC RA Policy and Advocacy

Gilead Sciences, United Kingdom -
Lene Kirstein, MPharm • Head of Regulatory Science & Policy

H. Lundbeck A/S, Denmark -
Martin O'Kane • Regional Head RA EU Policy & Liaison

Novartis Pharmaceuticals, United Kingdom -
Susan M Sandler, RPh • Director, Global Regulatory Policy and Intelligence

Johnson & Johnson, United Kingdom -
Jens-Ulrich Stegmann, MD, RN • Senior Vice President, Head Clinical Safety and Pharmacovigilance and EU QPPV

GSK , Belgium -
Jonathan Sutch, PhD • Principal Medicinal Technical Specialist

BSI Group, United Kingdom -
Sarah Vaughan • Head of Vigilance Operations

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Gabriel Westman, MD, PhD, MSc • Head of Artificial Intelligence

Swedish Medical Products Agency, Sweden -
Kathleen Grieve • Director - European Public Policy Access, Pricing and Affordability Policy Lead

MSD Europe Belgium SRL/BV, Belgium -
Sini Eskola, MPharm, MS, MSc • Head of International Regulatory Policy and Innovation

Takeda, Belgium -
Nick Sykes, MS • Policy Advisor, Regulatory Strategy

EFPIA, Belgium -
Marianne Lunzer, DrMed • Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care

AGES, Austria -
Benjamin Gannon • VP international markets

Guardant, United States -
Ditte Zerlang Andersen, PhD, MSc • Senior Strategy Project Lead

Danish Medicines Agency (DKMA), Denmark -
Clare Baledran • VP Precision medicines

Novo Nordisk, Denmark -
Thierry Sirdey • Team lead Innovation and Operational Excellence

ProductLife Group, France -
Antonia Morga • Head, New Product Planning, Global Value Evidence

Astellas Pharma Europe Ltd, United Kingdom
